title: Development of in situ gelling and bio adhesive 5-Fluorouracil enema.
abstract: In this study, a novel 5-Fluorouracil (5-FU) enema with good bio adhesion and temperature sensitivity was developed using in situ gelling technology. The preparation was formulated as a free-flowing liquid before use, while a layer of gel film was quickly formed when administered in the rectum, with a large contact surface area. It also demonstrated good biocompatibility, appropriate gel strength and bio adhesive force with excellent adhesion to rectal mucosa and prolonged action time, allowing more effective drug absorption and diffusion to surrounding tissues. Poloxamer 407 and poloxamer 188 were applied to adjust the gelling temperature. With the addition of carbopol and polycarbophil (bio adhesive substances), the solubility of 5-FU and gel strength increased, the temperature of gelation and the surface area of drug contact on mucous epithelium decreased. Decreased adhesive force between the preparation and the mucous membrane of the rectum was demonstrated with improving carbopol and polycarbophil's concentration. In vitro release demonstrated that 5-FU in situ gelling enema with different bases had a rapid and almost complete drug release. We used an optimized formulation of P407/P188/polycarbophil/5-FU (17/2.5/0.2/1.0) for animal experiments. The result showed that the drug evenly covered the surface of the rectum and there was no leakage in 6 hours. The in situ gelling enema showed significantly higher rectal tissue levels of 5-FU compared with suppository and intravenous administration, indicating that 5-FU could be well absorbed due to the enlarged releasing area, longer retention time and larger amount of dissolved active ingredients. Systemically, 5-FU levels in the enema group were similar to those in the suppository group and significantly lower than the intravenous group. The enema was not associated with morphological damage to rectal tissue. These results suggest that the bio adhesive and in situ gelling enema could be a more effective rectal delivery system of 5-FU.
authors: Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing City Key Laboratory of Drug Delivery Technology and Novel Formulations, Beijing, China.
authors: Lu-Lu
authors: LL
authors: Wang
authors: Wen-Sheng
authors: WS
authors: Zheng
authors: Shao-Hua
authors: SH
authors: Chen
authors: Xia-Qin
authors: XQ
authors: Fang
mesh_terms: D000180:Acrylic Resins / Q000737:chemistry; D000268:Adhesiveness; D000285:Administration, Rectal; D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000493:pharmacokinetics*; D001682:Biological Availability; D003692:Delayed-Action Preparations; D004733:Enema; D005472:Fluorouracil / Q000493:pharmacokinetics*; D005782:Gels; D008297:Male; D009092:Mucous Membrane / Q000187:drug effects*; D044367:Phase Transition; D020442:Poloxamer / Q000737:chemistry; D011145:Polyvinyls / Q000737:chemistry; D011817:Rabbits; D012007:Rectum / Q000187:drug effects*; D012995:Solubility; D013696:Temperature; D014014:Tissue Adhesives / Q000737:chemistry
chemical_list: D000180:Acrylic Resins; D000964:Antimetabolites, Antineoplastic; D003692:Delayed-Action Preparations; D005782:Gels; D011145:Polyvinyls; D014014:Tissue Adhesives; C006912:carboxypolymethylene; D020442:Poloxamer; C030312:calcium polycarbophil; D005472:Fluorouracil
references: Br J Cancer. 1985 Jul;52(1):15-20
references: 4015949
references: Jpn J Surg. 1980 Jun;10(2):110-4
references: 7431683
references: Cancer Res. 1980 Jul;40(7):2223-8
references: 7388790
references: Int J Pharm. 2012 Jul 1;430(1-2):114-9
references: 22503953
references: Int J Colorectal Dis. 2012 Jul;27(7):869-78
references: 22222465
references: Semin Oncol. 1999 Dec;26(6):589-605
references: 10606252
references: Crit Rev Ther Drug Carrier Syst. 1988;5(1):21-67
references: 3293807
references: J Pharm Pharmacol. 1984 May;36(5):295-9
references: 6145763
references: J Clin Oncol. 1985 Mar;3(3):402-6
references: 3973651
references: Pharm Res. 1992 Jan;9(1):70-5
references: 1589412
references: Cancer. 1993 Jun 1;71(11):3690-6
references: 8490919
references: Am J Surg. 1977 Mar;133(3):346-50
references: 848665
references: Conn Med. 1992 Jan;56(1):7-9
references: 1547634
references: Ann Surg Oncol. 1996 May;3(3):270-6
references: 8726182
references: Radiology. 1993 Aug;188(2):423-6
references: 8327689
references: Eur J Pharm Biopharm. 2008 May;69(1):167-75
references: 18023982
references: Ann Oncol. 1993;4 Suppl 2:21-8
references: 8353101
references: J Control Release. 2001 Jan 29;70(1-2):157-67
references: 11166416
references: Int J Pharm. 1999 Nov 5;189(2):137-45
references: 10536242
references: Drug Deliv. 2006 Mar-Apr;13(2):143-8
references: 16423803
references: Int J Pharm. 2004 May 19;276(1-2):83-92
references: 15113617
references: Drug Dev Ind Pharm. 2001 Apr;27(4):351-7
references: 11411903
references: Adv Drug Deliv Rev. 2002 Jan 17;54(1):37-51
references: 11755705
references: Int J Radiat Oncol Biol Phys. 1993 Apr 2;25(5):821-7
references: 8478232
references: J Control Release. 1999 May 20;59(2):163-72
references: 10332051
references: Int J Pharm. 2001 Sep 11;226(1-2):195-205
references: 11532582
references: Int J Pharm. 2003 Sep 16;263(1-2):105-11
references: 12954185
references: AAPS PharmSciTech. 2009;10(3):724-31
references: 19479384
references: Am J Surg. 1988 Jul;156(1):58-62
references: 3394895
references: Eur J Pharm Biopharm. 2012 Apr;80(3):585-95
references: 22182528
references: J Pharm Sci. 2000 Jul;89(7):835-49
references: 10861585
references: J Pharm Sci. 1980 Dec;69(12):1428-31
references: 7463330
references: Eur J Pharm Sci. 2004 Dec;23(4-5):347-53
references: 15567287
references: Biomacromolecules. 2011 Jan 10;12(1):28-33
references: 21142090
references: Am J Surg. 1982 Feb;143(2):183-5
references: 7058985
references: Eur J Pharm Sci. 2002 Aug;16(3):185-92
references: 12128173
references: Br J Cancer. 1992 Jan;65(1):133-5
references: 1733436
references: Biomaterials. 1994 Feb;15(3):177-82
references: 8199290
references: J Control Release. 2000 Jul 3;67(2-3):191-202
references: 10825553